Monninger, Maximilian
Aggensteiner, Pascal-M.
Pollok, Tania M.
Kaiser, Anna
Reinhard, Iris
Hermann, Andrea
Reichert, Markus
Ebner-Priemer, Ulrich W.
Meyer-Lindenberg, Andreas
Brandeis, Daniel
Banaschewski, Tobias
Holz, Nathalie E.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG HO 5674/2-1, GRK2350/1)
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
Zentralinstitut für Seelische Gesundheit (ZI)
Article History
Received: 27 October 2022
Accepted: 1 March 2023
First Online: 4 March 2023
Competing interests
: T.B. served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fees from Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. D.B. serves as an unpaid scientific consultant for an EU-funded neurofeedback trial unrelated to the present work. A.M.-L. has received consultancy fees from the American Association for the Advancement of Science, Atheneum Partners, Blueprint Partnership, Boehringer Ingelheim, Daimler und Benz Stiftung, Elsevier, F. Hoffmann-La Roche, ICARE Schizophrenia, K. G. Jebsen Foundation, L.E.K Consulting, Lundbeck International Foundation (LINF), R. Adamczak, Roche Pharma, Science Foundation, Sumitomo Dainippon Pharma, Synapsis Foundation – Alzheimer Research Switzerland, and System Analytics, and has received lecture fees including travel expenses from Boehringer Ingelheim, Fama Public Relations, Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Janssen-Cilag, Klinikum Christophsbad, Göppingen, Lilly Deutschland, Luzerner Psychiatrie, LVR Klinikum Düsseldorf, LWL Psychiatrie Verbund Westfalen-Lippe, Otsuka Pharmaceuticals, Reunions i Ciencia S. L., Spanish Society of Psychiatry, Südwestrundfunk Fernsehen, Stern TV, and Vitos Klinikum Kurhessen. U. W. E.-P. has received consultancy fees from Boehringer Ingelheim.